Tirdzniecība Fresenius Medical Care AG & Co KGaA - FME CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.57 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.019277% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.002946% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | EUR | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | Germany | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Fresenius Medical Care AG & Co KGaA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Iepriekš. aizvērt* | 38.82 |
Atvērt* | 38.64 |
Izmaiņas par 1 gadu* | -35.47% |
Dienas Diapazons* | 38.43 - 39.5 |
52 ned Diapazons | 25.95-63.66 |
Vidējais apjoms (10 dienas) | 1.14M |
Vidējais apjoms (3 mēneši) | 17.41M |
Tirgus Kapitalizācija | 11.40B |
Cenas/Peļņas Attiecība | 16.92 |
Izvietotās Akcijas | 293.41M |
Ieņēmumi | 19.40B |
EPS | 2.30 |
Dividende (Ienesīgums %) | 2.88214 |
Beta | 0.84 |
Nākamās Peļņas Datums | May 9, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Mar 30, 2023 | 38.82 | 0.73 | 1.92% | 38.09 | 38.87 | 37.43 |
Mar 29, 2023 | 38.10 | -0.10 | -0.26% | 38.20 | 38.50 | 37.78 |
Mar 28, 2023 | 38.22 | -0.15 | -0.39% | 38.37 | 38.66 | 37.65 |
Mar 27, 2023 | 38.48 | 1.00 | 2.67% | 37.48 | 38.57 | 37.25 |
Mar 24, 2023 | 37.01 | -0.58 | -1.54% | 37.59 | 37.73 | 36.32 |
Mar 23, 2023 | 37.87 | 0.54 | 1.45% | 37.33 | 37.96 | 37.12 |
Mar 22, 2023 | 37.63 | 0.49 | 1.32% | 37.14 | 37.95 | 37.14 |
Mar 21, 2023 | 37.03 | 0.62 | 1.70% | 36.41 | 37.20 | 36.26 |
Mar 20, 2023 | 36.32 | -0.24 | -0.66% | 36.56 | 37.14 | 35.71 |
Mar 17, 2023 | 36.52 | -0.16 | -0.44% | 36.68 | 37.73 | 35.77 |
Mar 16, 2023 | 36.62 | -0.31 | -0.84% | 36.93 | 37.27 | 36.34 |
Mar 15, 2023 | 36.85 | -0.44 | -1.18% | 37.29 | 37.46 | 36.47 |
Mar 14, 2023 | 37.16 | -0.02 | -0.05% | 37.18 | 37.30 | 36.42 |
Mar 13, 2023 | 37.06 | 0.31 | 0.84% | 36.75 | 37.51 | 36.08 |
Mar 10, 2023 | 36.99 | 1.26 | 3.53% | 35.73 | 36.99 | 35.65 |
Mar 9, 2023 | 36.31 | 0.29 | 0.81% | 36.02 | 36.45 | 35.84 |
Mar 8, 2023 | 36.24 | 0.51 | 1.43% | 35.73 | 36.25 | 35.69 |
Mar 7, 2023 | 36.06 | -0.53 | -1.45% | 36.59 | 36.78 | 35.84 |
Mar 6, 2023 | 37.45 | 0.61 | 1.66% | 36.84 | 37.71 | 36.69 |
Mar 3, 2023 | 36.50 | 0.79 | 2.21% | 35.71 | 36.51 | 35.67 |
Fresenius Medical Care AG & Co KGaA Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kopējie ienākumi | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
Ienākumi | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
Cost of Revenue, Total | 14087.8 | 12541.7 | 12321.6 | 12080.7 | 11392.1 |
Bruto Peļņa | 5310.25 | 5077.03 | 5537.44 | 5395.85 | 5154.74 |
Kopējie Darbības Izdevumi | 17886.3 | 15766.4 | 15554.7 | 15207 | 13509.1 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 3528.86 | 2996.98 | 3102.8 | 2939.13 | 2709.78 |
Pētniecība un Attīstība | 218.63 | 214.345 | 188.75 | 164.976 | 133.274 |
Depreciation / Amortization | 9.994 | 6.437 | 5.024 | 3.052 | 0.341 |
Procentu Izdevumi (Ienākumi) - Neto Darbība | 29.864 | -26.024 | -115.456 | -73.611 | -65.408 |
Neparedzēti Izdevumi (Ienākumi) | 11.147 | 33.005 | 51.92 | 92.744 | -661.043 |
Darbības Izdevumi | 1511.76 | 1852.29 | 2304.41 | 2269.56 | 3037.8 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -292.476 | -280.429 | -368.019 | -429.444 | -301.062 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 1219.28 | 1571.86 | 1936.39 | 1840.11 | 2736.74 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 894.325 | 1219.03 | 1435.83 | 1438.5 | 2225.66 |
Mazākuma Interese | -220.92 | -249.72 | -271.455 | -238.881 | -243.733 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Neto Ienākumi | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Atšķaidītie Neto Ienākumi | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
Atšķaidītie Ienākumi par Akcijām | 293.246 | 292.945 | 294.056 | 302.691 | 307.275 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 2.29638 | 3.30884 | 3.95972 | 3.96318 | 6.45 |
Dividends per Share - Common Stock Primary Issue | 1.12 | 1.35 | 1.34 | 1.2 | 1.17 |
Atšķaidītā Normalizētā Peļņa par Akciju | 3.98317 | 3.79414 | 4.71608 | 4.2027 | 4.70044 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kopējie ienākumi | 4996.8 | 5096.17 | 4756.68 | 4548.37 | 4647.02 |
Ienākumi | 4996.8 | 5096.17 | 4756.68 | 4548.37 | 4647.02 |
Cost of Revenue, Total | 3649.28 | 3737.58 | 3410.63 | 3290.27 | 3327.86 |
Bruto Peļņa | 1347.52 | 1358.59 | 1346.05 | 1258.09 | 1319.16 |
Kopējie Darbības Izdevumi | 4644.87 | 4624.52 | 4416.17 | 4200.7 | 4197.87 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 954.297 | 989.607 | 969.489 | 871.241 | 823.21 |
Pētniecība un Attīstība | 59.237 | 58.452 | 53.334 | 47.607 | 65.701 |
Depreciation / Amortization | 2.812 | 3.032 | 2.084 | 2.066 | 2.057 |
Procentu Izdevumi (Ienākumi) - Neto Darbība | -19.257 | -17.448 | -19.367 | -10.487 | -20.961 |
Darbības Izdevumi | 351.934 | 471.643 | 340.51 | 347.668 | 449.155 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -75.315 | -76.485 | -71.579 | -69.097 | -66.712 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 276.619 | 395.158 | 268.931 | 278.571 | 382.443 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 193.582 | 282.932 | 206.005 | 211.806 | 303.741 |
Mazākuma Interese | -54.778 | -52.832 | -58.865 | -54.445 | -75 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Neto Ienākumi | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Atšķaidītie Neto Ienākumi | 138.804 | 230.1 | 147.14 | 157.361 | 228.741 |
Atšķaidītie Ienākumi par Akcijām | 293.415 | 293.413 | 293.145 | 293.007 | 293 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.47306 | 0.78422 | 0.50194 | 0.53706 | 0.78069 |
Dividends per Share - Common Stock Primary Issue | 1.12 | 0 | 0 | 0 | 1.35 |
Atšķaidītā Normalizētā Peļņa par Akciju | 1.47121 | 0.42868 | 0.70576 | 0.64864 | 1.14933 |
Neparedzēti Izdevumi (Ienākumi) | -1.503 | -146.699 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 7967.24 | 7275.31 | 7165.15 | 7846.89 | 6374.31 |
Nauda un Īstermiņa Ieguldījumi | 1618.02 | 1243.23 | 1141.05 | 2265.14 | 993.574 |
Cash | 925.134 | 746.851 | 768.706 | 831.885 | 620.145 |
Nauda un Ekvivalenti | 556.521 | 334.688 | 239.017 | 1313.75 | 357.964 |
Īstermiņa Ieguldījumi | 136.362 | 161.688 | 133.322 | 119.507 | 15.465 |
Debitoru Parādu Kopsumma, Neto | 3769.23 | 3579.29 | 3969.26 | 3765.57 | 3696.15 |
Accounts Receivable - Trade, Net | 3409.06 | 3153.04 | 3421.35 | 3337.71 | 3389.33 |
Total Inventory | 2038.01 | 1895.31 | 1663.28 | 1466.8 | 1290.78 |
Prepaid Expenses | 377.907 | 374.081 | 178.474 | 135.729 | 124.162 |
Other Current Assets, Total | 164.07 | 183.398 | 213.086 | 213.646 | 269.64 |
Total Assets | 34366.6 | 31689 | 32934.7 | 26242.3 | 24025.2 |
Property/Plant/Equipment, Total - Net | 8551.47 | 8186.75 | 8515.4 | 3836.01 | 3491.77 |
Property/Plant/Equipment, Total - Gross | 16654.3 | 14830.4 | 14413.4 | 8507.4 | 7655.4 |
Accumulated Depreciation, Total | -8102.86 | -6643.68 | -5897.98 | -4671.39 | -4163.63 |
Goodwill, Net | 14361.6 | 12958.7 | 14017.3 | 12209.6 | 12103.9 |
Intangibles, Net | 1459.39 | 1381.01 | 1426.33 | 681.331 | 683.058 |
Long Term Investments | 786.905 | 761.113 | 696.872 | 649.78 | 647.009 |
Other Long Term Assets, Total | 1239.97 | 1126.12 | 1113.74 | 1018.66 | 725.149 |
Total Current Liabilities | 7257.63 | 6159.64 | 7007.23 | 6268.28 | 5299.89 |
Accounts Payable | 736.069 | 731.993 | 716.526 | 641.271 | 590.493 |
Accrued Expenses | 2225.56 | 2115.75 | 1964.24 | 2056.49 | 2056.18 |
Notes Payable/Short Term Debt | 1255.85 | 79.27 | 1171.85 | 1394.19 | 769.279 |
Current Port. of LT Debt/Capital Leases | 1329.54 | 1617.52 | 2086.16 | 1244.73 | 994.731 |
Other Current Liabilities, Total | 1710.61 | 1615.11 | 1068.46 | 931.597 | 889.211 |
Total Liabilities | 21667.8 | 20474 | 20976.8 | 14483.9 | 14205.1 |
Total Long Term Debt | 10734.8 | 10683.2 | 10524.6 | 5045.52 | 5794.87 |
Long Term Debt | 6646.95 | 6800.1 | 6458.32 | 5018.76 | 5766 |
Capital Lease Obligations | 4087.8 | 3883.13 | 4066.3 | 26.757 | 28.873 |
Deferred Income Tax | 868.452 | 785.886 | 739.702 | 626.521 | 467.54 |
Minority Interest | 1280.25 | 1116.23 | 1269.32 | 1143.55 | 1008.08 |
Other Liabilities, Total | 1526.68 | 1728.96 | 1435.95 | 1399.99 | 1634.72 |
Total Equity | 12698.8 | 11215.1 | 11957.9 | 11758.4 | 9820.1 |
Common Stock | 293.004 | 292.877 | 304.437 | 307.879 | 308.111 |
Additional Paid-In Capital | 2891.28 | 2872.63 | 3607.66 | 3873.34 | 3969.25 |
Retained Earnings (Accumulated Deficit) | 10826.1 | 10254.9 | 9454.86 | 8831.93 | 7137.25 |
Treasury Stock - Common | 0 | -370.502 | -50.993 | -108.931 | |
Other Equity, Total | -1311.64 | -2205.34 | -1038.55 | -1203.75 | -1485.58 |
Total Liabilities & Shareholders’ Equity | 34366.6 | 31689 | 32934.7 | 26242.3 | 24025.2 |
Total Common Shares Outstanding | 293.004 | 292.877 | 298.329 | 306.879 | 306.451 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 8039.39 | 7967.24 | 7998.91 | 7814.68 | 7789.41 |
Nauda un Īstermiņa Ieguldījumi | 1173.34 | 1481.66 | 1561.83 | 1407.96 | 1073.48 |
Nauda un Ekvivalenti | 1173.34 | 556.521 | 1561.83 | 1407.96 | 1073.48 |
Debitoru Parādu Kopsumma, Neto | 3890.82 | 3571.42 | 3449.86 | 3526.45 | 3894.15 |
Accounts Receivable - Trade, Net | 3707.49 | 3409.06 | 3323.6 | 3419.51 | 3740.71 |
Total Inventory | 2136.96 | 2038.01 | 2119.8 | 2052.94 | 1989.41 |
Other Current Assets, Total | 838.272 | 876.151 | 867.414 | 827.332 | 832.376 |
Total Assets | 34724.1 | 34366.6 | 33830.9 | 32987.2 | 33158.5 |
Property/Plant/Equipment, Total - Net | 8510.45 | 8551.47 | 8391.22 | 8320.06 | 8415.64 |
Goodwill, Net | 14628.7 | 14361.6 | 13901.4 | 13495.5 | 13638.9 |
Intangibles, Net | 1480.42 | 1459.39 | 1418.94 | 1395.03 | 1401.5 |
Long Term Investments | 798.947 | 786.905 | 742.799 | 708.56 | 726.595 |
Other Long Term Assets, Total | 1266.2 | 1239.97 | 1377.62 | 1253.37 | 1186.48 |
Total Current Liabilities | 6377.45 | 7257.63 | 7492.3 | 7424.63 | 7242.97 |
Accounts Payable | 790.236 | 736.069 | 706.385 | 684.981 | 635.422 |
Accrued Expenses | 3515.83 | 3676.88 | 3885.14 | 3850.79 | 3792.75 |
Notes Payable/Short Term Debt | 1115.21 | 1255.85 | 1363.29 | 1385.03 | 1140.62 |
Current Port. of LT Debt/Capital Leases | 730.959 | 1329.54 | 1293.77 | 1261.47 | 1423.64 |
Other Current Liabilities, Total | 225.212 | 259.293 | 243.715 | 242.356 | 250.54 |
Total Liabilities | 21489.6 | 21667.8 | 21601.2 | 21355.3 | 21160.5 |
Total Long Term Debt | 11497.2 | 10734.8 | 10570.1 | 10469 | 10336.2 |
Long Term Debt | 7451.79 | 6646.95 | 6571.22 | 6499 | 6315.27 |
Capital Lease Obligations | 4045.41 | 4087.8 | 3998.86 | 3970.02 | 4020.95 |
Deferred Income Tax | 896.38 | 868.452 | 863.9 | 800.492 | 809.215 |
Minority Interest | 1304.8 | 1280.25 | 1216.24 | 1180.48 | 1201.58 |
Other Liabilities, Total | 1413.8 | 1526.68 | 1458.73 | 1480.62 | 1570.47 |
Total Equity | 13234.5 | 12698.8 | 12229.7 | 11632 | 11998.1 |
Common Stock | 293.027 | 293.004 | 292.994 | 292.979 | 292.888 |
Additional Paid-In Capital | 2891.74 | 2891.28 | 2884.96 | 2886.97 | 2887.04 |
Retained Earnings (Accumulated Deficit) | 11027.2 | 10826.1 | 10567.7 | 10290.6 | 10500 |
Other Equity, Total | -977.445 | -1311.64 | -1515.97 | -1838.63 | -1681.86 |
Total Liabilities & Shareholders’ Equity | 34724.1 | 34366.6 | 33830.9 | 32987.2 | 33158.5 |
Total Common Shares Outstanding | 293.027 | 293.004 | 292.994 | 292.979 | 292.888 |
Cash | 925.134 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | 1219.03 | 1435.83 | 1438.5 | 2225.66 | 1554.53 |
Nauda no Darbības | 2489.5 | 4233.16 | 2566.95 | 2061.91 | 2191.81 |
Nauda no Darbības | 1623.68 | 1785.9 | 1593.16 | 724.847 | 735.479 |
Deferred Taxes | 67.259 | 111.104 | 64.266 | 89.171 | -203.046 |
Bezskaidras Naudas Preces | 232.342 | 215.137 | 304.705 | -824.73 | -126.822 |
Cash Taxes Paid | 345.052 | 301.663 | 387.719 | 358.386 | 674.625 |
Samaksātie Procenti Naudā | 341.629 | 379.994 | 470.223 | 311.971 | 339.088 |
Izmaiņas Apgrozāmajā Kapitālā | -652.807 | 685.184 | -833.68 | -153.034 | 231.666 |
Nauda no Ieguldījumu Darbībām | -1196.23 | -1334.94 | -3285.99 | -245.039 | -991.541 |
Kapitālie Izdevumi | -886.715 | -1085.23 | -1162.76 | -1142.38 | -970.83 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -309.513 | -249.709 | -2123.22 | 897.34 | -20.711 |
Nauda no Darbībām ar Finansēšanu | -1024.38 | -2664.03 | -466.633 | -681.736 | -798.63 |
Naudas Plūsma Finansēšanas Posteņos | -279.535 | -693.531 | 153.387 | -528.009 | -185.979 |
Total Cash Dividends Paid | -392.455 | -351.17 | -354.636 | -324.838 | -293.973 |
Akciju Izsniegšana (Atkāpšanās), Neto | 6.511 | -353.335 | -583.932 | 10.183 | -10.347 |
Parādu Izsniegšana (Atkāpšanās), Neto | -358.903 | -1265.99 | 318.548 | 160.928 | -308.331 |
Ārvalstu Valūtas Ietekme | 131.228 | -160.371 | 47.76 | 32.387 | -132.413 |
Neto Izmaiņas Naudā | 400.116 | 73.816 | -1137.91 | 1167.52 | 269.227 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 211.806 | 1219.03 | 915.287 | 584.052 | 304.334 |
Cash From Operating Activities | 158.697 | 2489.5 | 1820.45 | 1128.77 | 207.648 |
Cash From Operating Activities | 418.957 | 1623.68 | 1186.57 | 783.735 | 388.202 |
Deferred Taxes | -9.295 | 67.259 | -12.828 | -36.814 | -6.054 |
Non-Cash Items | 54.974 | 232.342 | 116.658 | 91.471 | 40.292 |
Cash Taxes Paid | 44.301 | 345.052 | 268.11 | 209.901 | 41.793 |
Cash Interest Paid | 79.484 | 341.629 | 255.162 | 171.384 | 104.607 |
Changes in Working Capital | -517.745 | -652.807 | -385.234 | -293.674 | -519.126 |
Cash From Investing Activities | -211.316 | -1196.23 | -773.438 | -473.178 | -224.053 |
Capital Expenditures | -198.313 | -854.36 | -858.778 | -522.335 | -290.79 |
Other Investing Cash Flow Items, Total | -13.003 | -341.868 | 85.34 | 49.157 | 66.737 |
Cash From Financing Activities | -266.641 | -1024.38 | -666.849 | -378.319 | -35.915 |
Financing Cash Flow Items | 464.211 | -279.535 | -208.996 | -133.871 | -47.907 |
Issuance (Retirement) of Stock, Net | 0.792 | 6.511 | 6.005 | 5.228 | 0.575 |
Issuance (Retirement) of Debt, Net | -731.644 | -358.903 | -71.403 | 142.779 | 11.417 |
Foreign Exchange Effects | 10.947 | 131.228 | 100.131 | 49.146 | 44.259 |
Net Change in Cash | -308.313 | 400.116 | 480.295 | 326.419 | -8.061 |
Total Cash Dividends Paid | -392.455 | -392.455 | -392.455 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Fresenius SE & Co KGaA | Corporation | 32.1663 | 94380382 | 0 | 2023-02-21 | LOW |
Pzena Investment Management, LLC | Investment Advisor/Hedge Fund | 5.2 | 15257499 | 6433048 | 2023-01-02 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.105 | 12044710 | 1321531 | 2023-03-17 | LOW |
Harris Associates L.P. | Investment Advisor/Hedge Fund | 3.0098 | 8831173 | 15678 | 2023-02-28 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 3.0017 | 8807448 | -5315479 | 2023-01-03 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 2.9941 | 8785062 | 0 | 2023-01-02 | LOW |
Templeton Investment Counsel, L.L.C. | Investment Advisor/Hedge Fund | 2.659 | 7801761 | 200236 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.037 | 5976971 | 13981 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.2147 | 3564186 | -379946 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.0855 | 3185091 | 105743 | 2023-02-28 | LOW |
Fidelity International | Investment Advisor | 0.9623 | 2823645 | 47140 | 2023-01-31 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8519 | 2499677 | -3590 | 2023-02-28 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5802 | 1702442 | 36990 | 2023-02-28 | LOW |
Macquarie Investment Management | Investment Advisor | 0.5594 | 1641311 | -6380 | 2023-02-28 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.5432 | 1593946 | 25473 | 2023-02-28 | LOW |
Fiduciary Management, Inc. | Investment Advisor | 0.506 | 1484650 | 130000 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4893 | 1435667 | 839 | 2023-02-28 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4514 | 1324441 | 10743 | 2023-02-28 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.4436 | 1301694 | 81837 | 2023-02-28 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.4212 | 1235851 | 0 | 2023-02-28 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Fresenius Medical Care Company profile
Par Fresenius Medical Care AG & Co KGaA
Fresenius Medical Care AG & Co. KGaA ir Vācijā bāzēts nieru dialīzes institūts. Uzņēmums sniedz dialīzes aprūpi un ar to saistītus pakalpojumus personām, kas slimo ar nieru slimību pēdējā stadijā (ESRD), kā arī citus veselības aprūpes pakalpojumus. Uzņēmums arī izstrādā un ražo dažādus veselības aprūpes produktus, tostarp dialīzes un ar dialīzi nesaistītus produktus. Tā dialīzes produkti ietver hemodialīzes aparātus, peritoneālos ciklerus, dializatorus, peritoneālos šķīdumus un granulas, asinsvadus, nieru farmaceitiskos līdzekļus un ūdens attīrīšanas sistēmas. Tā nedialīzes produkti ietver akūtās kardiopulmonālās un aferēzes produktus. Uzņēmums ar plašu produktu klāstu apgādā tam piederošās, pārvaldītās vai vadītās dialīzes klīnikas un pārdod dialīzes produktus citiem dialīzes pakalpojumu sniedzējiem.
Industry: | Healthcare Facilities & Services (NEC) |
Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com